Changes in Fertility and Hormone Replacement Therapy in Kidney Disease

Advances in Chronic Kidney Disease

Volumn 20, Issue 3, 2013, Pages 240-245

  Holley, Jean L ^a   Schmidt, Rebecca J ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Anovulation; CKD; ESRD; Infertility

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; ANDROGEN; BROMOCRIPTINE; C REACTIVE PROTEIN; CONJUGATED ESTROGEN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ESTRADIOL; ESTROGEN; ESTRONE SULFATE; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUMAN MENOPAUSAL GONADOTROPIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PARATHYROID HORMONE[1-34]; PHOSPHODIESTERASE INHIBITOR; PROLACTIN; RALOXIFENE; TESTOSTERONE; TESTOSTERONE CIPIONATE; URIC ACID; VITAMIN D; ZINC;

ANDROGEN DEFICIENCY; BONE DENSITY; CHRONIC KIDNEY DISEASE; CLINICAL DECISION MAKING; DISEASE EXACERBATION; ESTROGEN METABOLISM; ESTROGEN THERAPY; FEMALE FERTILITY; FEMALE INFERTILITY; HEMODIALYSIS; HOME DIALYSIS; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE FERTILITY; MALE INFERTILITY; MALE SEXUAL DYSFUNCTION; OSTEOPOROSIS; OVARY FUNCTION; OVULATION; OXIDATIVE STRESS; POSTMENOPAUSE; PREGNANCY RATE; PREGNANCY TERMINATION; PREMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEXUAL DYSFUNCTION; SEXUAL SATISFACTION; SPERMATOCYTE; SPERMATOGENESIS; SPERMATOZOON COUNT; SPONTANEOUS ABORTION; TESTIS FUNCTION; TRANSDERMAL PATCH; VAGINA ATROPHY; VASOMOTOR DISORDER;

ANDROGENS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; INFERTILITY, FEMALE; INFERTILITY, MALE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE;

EID: 84876842200     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2013.01.003     Document Type: Review

References (50)

1. Palmer B.F. Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease. Adv Ren Replac Ther 2003, 10(1):48-60.
2. Schmidt R.J., Holley J.L. Fertility and contraception in end-stage renal disease. Adv Ren Replac Ther 1998, 5(1):38-44.
3. Malatesta M.F.D., Rossi M., Rocca B., et al. Fertility following solid organ transplantation. Transplant Proc 2007, 39(6):2001-2004.
4. Hou S. Pregnancy in women on dialysis: is success a matter of time?. Clin J Am Soc Nephrol 2008, 3(2):312-313.
5. Barua M., Hladunewich M., Keunen J., et al. Successful pregnancies on nocturnal home hemodialysis. Clin J Am Soc Nephrol 2008, 3(2):392-396.
6. Bass A., Ahmed S.B., Klarenbach S., et al. The impact of nocturnal hemodialysis on sexual function. BMC Nephrol 2012, 13:1-7.
7. Lim V.S., Henriquez C., Sivertsen G., et al. Ovarian function in chronic renal failure: evidence suggesting hypothalamic anovulation. Ann Intern Med 1980, 93(1):21-27.
8. Holley J.L., Schmidt R.J., Bender F., et al. Gynecologic and reproductive issues in women on dialysis. Am J Kidney Dis 1997, 29(5):685-690.
9. Strippoli G.F. Sexual dysfunction in women with ESRD requiring hemodialysis. Clin J Am Soc Nephrol 2012, 7(6):974-981. Collaborative Depression and Sexual Dysfunction in Hemodialysis Working Group.
10. van Eps C., Hawley C., Jeffries J., et al. Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis. Nephrology (Carlton) 2012, 17(1):42-47.
11. Okundaye I.B., Abrinko P., Hou S. A registry for pregnancy in dialysis patients. Am J Kidney Dis 1998, 31(5):766-773.
12. Wang G.-C., Zheng J.-H., Xu L.-G., et al. Measurements of serum pituitary-gonadal hormones and investigation of sexual and reproductive functions in kidney transplant recipients. Int J Nephrol 2010, 2010:1-6.
13. Holley J.L. The hypothalamic-pituitary axis in men and women with chronic kidney disease. Adv Chronic Kidney Dis 2004, 11(4):337-341.
14. Lim V.A. Reproductive function in patients with renal insufficiency. Am J Kidney Dis 1987, 9(4):363-367.
15. Handelsman D.J., Dong Q. Hypothalamo-pituitary gonadal axis in chronic renal failure. Endocrinol Metab Clin North Am 1993, 22(1):145-161.
16. Xu H.M., Li H.G., Xu L.G., Zhang J.R., Chen W.Y., Shi Q.X. The decline of fertility in male uremic patients is correlated with low expression of the cystic fibrosis transmembrane conductance regulator protein (CTFR) in human sperm. Hum Reprod 2012, 27(2):340-348.
17. Akbari F., Alavi M., Esteghamati A., et al. Effect of renal transplantation on sperm quality and sex hormone levels. BJU Int 2003, 92(3):281-283.
18. Navaneethan S.D., Vecchio M., Johnson D.W., et al. Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis 2010, 56(4):670-685.
19. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998, 280(7):605-613.
20. Grady D., Herrington D., Bittner V., et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). J Am Med Assoc 2002, 288(1):49-57.
21. Rosani G.M., Maffei S., Andreassi M.G., et al. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women. J Cardiovasc Med (Hagerstown) 2009, 10(1):85-92.
22. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002, 288(3):321-333.
23. Stehman-Breen C.O., Gillen D., Gipson D. Prescription of hormone replacement therapy in postmenopausal women with renal failure. Kidney Int 1999, 56(6):2243-2247.
24. Salamone L.M., Pressman A.R., Seeley D.G., Cauley J.A. Estrogen replacement therapy. A survey of older women's attitudes. Arch Intern Med 1996, 156(12):1293-1297.
25. Gipson D. Hormone replacement therapy (HRT) in ESRD. ANNA J 1999, 26(5):525-532.
26. Kramer H.M., Curhan G.C., Singh A. Permanent cessation of menses and postmenopausal hormone use in dialysis-dependent women: the HELP Study. Am J Kidney Dis 2003, 41(3):643-650.
27. Stehman-Breen C., Anderson G., Gibson D., Lausz A.T., Ott S. Pharmacokinetics of oral micronized beta-estradiol in postmenopausal women receiving maintenance hemodialysis. Kidney Int 2003, 64(1):290-294.
28. Anderson G.D., Odegard P.S. Pharmacokinetics of estrogen and progesterone in chronic kidney disease. Adv Chronic Kidney Dis 2004, 11(4):357-360.
29. Ginsburg E.S., Owen W.F., Greenberg L.M., Shea B.F., Lazarus J.M., Walsh B.W. Estrogen absorption and metabolism in postmenopausal women with end-stage renal disease. J Clin Endocrinol Metab 1996, 81(12):4414-4417.
30. Matuszkiewicz-Rowifiska J., Skorzewska K., Raowicki S., et al. The benefits of hormone replacement therapy in pre-menopausal women with estrogen deficiency on haemodialysis. Nephrol Dial Transplant 1999, 14(5):1238-1243.
31. Chang S.P., Yang W.S., Lee S.K., Min W.K., Park J.S., Kim S.B. Effects of hormonal replacement therapy on oxidative stress and total antioxidant capacity in postmenopausal hemodialysis patients. Ren Fail 2002, 24(1):49-57.
32. Park J.S., Jung H.H., Yang W.S., Kim S.B., Min W.K., Chi H.S. Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients. Nephrol Dial Transplant 2000, 15(11):1835-1840.
33. Ishani A., Blackwell T., Jamal S.A., Cummings S.R., Ensrud K.E. The effect of raloxifene treatment in postmenopausal women with CKD. J Am Soc Nephrol 2008, 19(7):1430-1438.
34. Hernandez E., Valera R., Alonao E., et al. Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis. Kidney Int 2003, 63(6):2269-2274.
35. Miller P.D., Schwartz E.N., Chen P., Misurski D.A., Krege J.H. Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int 2007, 18(1):59-68.
36. Carrero J.J., Qureshi A.R., Parini P., et al. Low serum testosterone increases mortality risk among male dialysis patients. J Am Soc Nephrol 2009, 20(3):613-620.
37. Johansen K.L. Testosterone metabolism and replacement therapy in patients with end-stage renal disease. Semin Dial 2004, 17(3):202-208.
38. Johansen K.L. Treatment of hypogonadism in men with chronic kidney disease. Adv Chronic Kidney Dis 2004, 11(4):348-356.
39. Bhasin S., Cunningham G.R., Hayes F.J., et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010, 95(6):2536-2559.
40. Carrero J.J., Stenvinkel P. The vulnerable man: impact of testosterone deficiency on the uraemic phenotype. Nephrol Dial Transplant 2012, 27(11):4030-4041.
41. Brockenbrough A.T., Dittrich M.O., Page S.T., et al. Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease. Am J Kidney Dis 2006, 47(2):251-262.
42. Van Coevorden A., Stolear J.C., Dhaene M., et al. Effect of chronic oral testosterone undecanoate administration on the pituitary-testicular axes of hemodialyzed male patients. Clin Nephrol 1986, 26(1):48-54.
43. Lawrence I.G., Price D.E., Howlett T.A., et al. Correcting impotence in the male dialysis patient: experience with testosterone replacement and vacuum tumescence therapy. Am J Kidney Dis 1998, 31(2):313-319.
44. Canguven O., Aykose G., Albayrak S., et al. Efficacy of testosterone gel in the treatment of erectile dysfunction in hypogonadal hemodialysis patients: a pilot study. Int J Impot Res 2010, 22(2):140-145.
45. Singh A.B., Norris K., Modi N., et al. Pharmacokinetics of a transdermal testosterone system in men with end-stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men. J Clin Endocrinol Metab 2001, 86(6):2437-2445.
46. Vecchio M., Navaneethan S.D., Johnson D.W., et al. Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials. Clin J Am Soc Nephrol 2010, 5(6):985-995.
47. Vecchio M., Navaneethan S.D., Johnson D.W., et al. Interventions for treating sexual dysfunction in patients with chronic kidney disease. Cochrane Database Syst Rev 2010, 12:CD007747.
48. Yilmaz M.I., Sonmez A., Qureshi A.R., et al. Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease. Clin J Am Soc Nephrol 2011, 6(7):1617-1625.
49. Kyriazis J., Tzanakis I., Stylianou K., et al. Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients. Nephrol Dial Transplant 2011, 26(9):2971-2977.
50. Kettas E., Cayan F., Akbay E., Kiykim A., Cayan S. Sexual dysfunction and associated risk factors in women with end-stage renal disease. J Sex Med 2008, 5(4):872-877.